Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Luciano Prossomariti"'
Autor:
Alessia Pepe, Antonella Meloni, Marcello Capra, Paolo Cianciulli, Luciano Prossomariti, Cristina Malaventura, Maria Caterina Putti, Alma Lippi, Maria Antonietta Romeo, Maria Grazia Bisconte, Aldo Filosa, Vincenzo Caruso, Antonella Quarta, Lorella Pitrolo, Massimiliano Missere, Massimo Midiri, Giuseppe Rossi, Vincenzo Positano, Massimo Lombardi, Aurelio Maggio
Publikováno v:
Haematologica, Vol 96, Iss 1 (2011)
Background Oral deferiprone was suggested to be more effective than subcutaneous desferrioxamine for removing heart iron. Oral once-daily chelator deferasirox has recently been made commercially available but its long-term efficacy on cardiac iron an
Externí odkaz:
https://doaj.org/article/6552031eb53d402d86fd2b4e79d29543
Autor:
Leonilde Pagano, Assunta Viola, Gennaro Fioretti, Massimiliano Ammirabile, Paolo Ricchi, Luciano Prossomariti
Publikováno v:
Haematologica, Vol 92, Iss 7 (2007)
Between January 1995 and December 2005, we conducted a screening program for the presence of Hb Neapolis, a rare abnormal Hb variant, in Campania, a region in Southern Italy. Nineteen patients with Hb Neapolis in heterozygosis and six patients with a
Externí odkaz:
https://doaj.org/article/3b801190546e4ef9b8833ec30d8d7097
Autor:
Angela Vitrano, Nipon Chattipakorn, Giuseppina Calvaruso, Liana Cuccia, Luigi Mancuso, Calogera Gerardi, John Walker, Paolo Rigano, Michel Angastiniotis, Luciano Prossomariti, Vincenzo Caruso, Aldo Filosa, Saveria Campisi, Arintaya Phrommintikul, Lorella Pitrolo, Paul Telfer, Paolo Cianciulli, Hala S. Hamza, Aurelio Maggio, Androulla Elefteriou, Marcello Capra, Rita Barone
Publikováno v:
Blood Cells, Molecules, and Diseases. 50:241-246
Cardiac damage remains a major cause of mortality among patients with thalassemia major. The detection of a lower cardiac magnetic resonance T2* (CMR-T2*) signal has been suggested as a powerful predictor of the subsequent development of heart failur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b34d99fda0fbfd767480bc05e51ce7
https://doi.org/10.1016/j.bcmd.2012.12.002
https://doi.org/10.1016/j.bcmd.2012.12.002
Autor:
Liana Cuccia, Luciano Prossomariti, Maria Fustaneo, Saveria Campisi, Giuseppina Calvaruso, Michele Rizzo, Francesco Gagliardotto, Grazia Colletta, Aldo Filosa, Rosario Di Maggio, Alessandra Quota, Aurelio Maggio, Vincenzo Caruso, Crocetta Argento, Lorella Pitrolo, Carmelo Fidone, Angela Vitrano, Luciana Rigoli, Calogera Gerardi, Eliana Lai
Publikováno v:
British journal of haematology. 176(1)
Summary In the last few decades, the life expectancy of regularly transfused β-thalassaemia major (TM) patients has dramatically improved following the introduction of safe transfusion practices, iron chelation therapy, aggressive treatment of infec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0d2a7e8eff8f13c6b208f5f51b88294
https://pubmed.ncbi.nlm.nih.gov/27748513
https://pubmed.ncbi.nlm.nih.gov/27748513
Autor:
Giovan Giuseppe Di Costanzo, Luciano Prossomariti, Alfonso Galeota Lanza, Anna Spasiano, Silvia Costantini, Paolo Ricchi, Patrizia Cinque, Tiziana Di Matola, Massimiliano Ammirabile, Leonilde Pagano
Publikováno v:
British Journal of Haematology. 155:524-527
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efaab1c05151b42551e1a431537c5e6e
https://doi.org/10.1111/j.1365-2141.2011.08717.x
https://doi.org/10.1111/j.1365-2141.2011.08717.x
Autor:
Tiziana Di Matola, Patrizia Cinque, Luciano Prossomariti, Alfonso Lanza Galeota, Paolo Ricchi, Massimiliano Ammirabile
Publikováno v:
International Journal of Hematology. 89:135-138
In this report we firstly describe a case of reactivation of hepatitis B virus (HBV) replication occurred in a patient affected by Thalassemia major which underwent a combined chelation therapy with desferioxamine (DFO) and deferiprone (DFP). Clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb435c150664e6aa87a907a41bea34b
https://doi.org/10.1007/s12185-008-0229-6
https://doi.org/10.1007/s12185-008-0229-6
Autor:
Ippazio Stefàno, Caterina Borgna-Pignatti, Luciano Prossomariti, Lorenzo G. Mantovani, S Ravera, Marieke Krol, Diana Rofail, Paolo Cianciulli, Maria Domenica Cappellini, Domenico Pietro Paolo Gallisai, Zelia Borsellino, Luciana Scalone, Maria Grazia Bisconte
Publikováno v:
Current Medical Research & Opinion, 24(7), 1905-1917. Taylor & Francis Ltd
Objectives: Iron chelation treatment (ICT) in β-thalassemia major (β-TM) patients undergoing blood transfusions can cause low satisfaction, low compliance, with possible negative consequences on treatment success, patients' wellbeing, and costs. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e5fe6f4564b08d4369eb530ff7ac276
https://doi.org/10.1185/03007990802160834
https://doi.org/10.1185/03007990802160834
Autor:
Angela Flagiello, Luciano Prossomariti, Massimiliano Ammirabile, Filiberto Pollio, Cristina Passarello, Roberta Tedesco, Antonino Giambona, Piero Pucci, Leonilde Pagano
Publikováno v:
Hemoglobin. 31:113-120
A high oxygen affinity hemoglobin (Hb) variant, Hb J-Cape Town [alpha92(FG4)Arg-->Gln (alpha1), CGG-->CAG] was identified in a 30-year-old woman patient from Cosenza (Southern Italy) who had previously been diagnosed with juvenile polycythemia in oth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dd60bc304a27d1791e29140d4d74942
https://doi.org/10.1080/03630260701277487
https://doi.org/10.1080/03630260701277487
Autor:
Luciano Prossomariti, Leonilde Pagano, Maria Rosaria D'Amico, Assunta Viola, Felicetto Ferrara, Rossella D'Elia, Daniela Laudati, Massimiliano Ammirabile, Salvatore Palmieri
Publikováno v:
Leukemia & Lymphoma. 47:2331-2334
An increased incidence of HFE gene mutations has been described in hematologic malignancies. In the present study, we investigated the allelic frequency of HFE gene mutations in 154 adult patients with acute leukemia (AL) [107 acute myeloid leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e04f6a41db9ca974e2d35ed1b2b1dbc0
https://doi.org/10.1080/10428190600821898
https://doi.org/10.1080/10428190600821898
Autor:
Silvia Costantini, Aldo Filosa, Tiziana Di Matola, Patrizia Cinque, Luciano Prossomariti, Maddalena Casale, Anna Spasiano, Massimiliano Ammirabile, Paolo Ricchi
Publikováno v:
Annals of Hematology. 93:525-527
Dear Editor, We refer this letter to the manuscript by Efthimia et al. [1] in which they recently reported that in thalassemia major (TM) patients, the start of deferasirox (DFX) has been associated with increased risk of developing nephrolithiasis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7d379af2802bbfdba8b748958b2cee7
https://doi.org/10.1007/s00277-013-1833-y
https://doi.org/10.1007/s00277-013-1833-y